Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.79)
# 3,345
Out of 5,090 analysts
57
Total ratings
51.35%
Success rate
-4.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Overweight | $350 → $360 | $316.45 | +13.76% | 6 | Nov 7, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $125.40 | +16.43% | 9 | Oct 16, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $193.76 | -5.04% | 5 | Aug 8, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $17.06 | +17.23% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $20.65 | +297.09% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $118.86 | +108.65% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $568.65 | -40.39% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.82 | +82.93% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $2.14 | +1,164.64% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $93.16 | +19.15% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $65.27 | +120.24% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $108.85 | -48.55% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $84.15 | -12.06% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $85.78 | -10.62% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $11.75 | +666.28% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $88.74 | - | 1 | Dec 12, 2019 |
Insulet
Nov 7, 2025
Maintains: Overweight
Price Target: $350 → $360
Current: $316.45
Upside: +13.76%
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $125.40
Upside: +16.43%
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $193.76
Upside: -5.04%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $17.06
Upside: +17.23%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $20.65
Upside: +297.09%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $118.86
Upside: +108.65%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $568.65
Upside: -40.39%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.82
Upside: +82.93%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $2.14
Upside: +1,164.64%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $93.16
Upside: +19.15%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $65.27
Upside: +120.24%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $108.85
Upside: -48.55%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $84.15
Upside: -12.06%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $85.78
Upside: -10.62%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $11.75
Upside: +666.28%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $88.74
Upside: -